Back to results
US 2023/0405053 A1Published application
Oral delivery of therapeutic mammalian cells
AssigneeVitabolus Inc.
InventorAline M. BETANCOURT
Life of this patent
Estimating the term…
Abstract
Described herein are oral delivery systems for use in delivering live mammalian cells to the intestinal tract of an individual.
Claims30
A composition of live mammalian cells formulated for oral delivery to an individual, the composition comprising (a) a matrix comprising about 0.5% to about 1.0% methyl cellulose and about 0.5% to about 1.0% alginate gel, and (b) a plurality of live mammalian cells, wherein the plurality of live mammalian cells is suspended in the matrix.
(canceled)
(canceled)
-28. (canceled)
-42. (canceled)
Dependencies are inferred from the claim text.